Home Biosimilar Antibodies Others Others antibody Ecromeximab (Anti-GD3) For research use only.
Not for use in humans.

Ecromeximab (Anti-GD3)

Synonyms: Monoclonal antibody KW-2871

Ecromeximab (Anti-GD3) is a human-mouse chimeric IgG1 monoclonal antibody with potential antineoplastic activity that targets ganglioside GD3, a surface antigen expressed on many malignant melanoma cells. It binds to GD3-positive cells, thereby initiating antibody-dependent cytotoxicity against GD3-positive cells. MW: 145.5 KD.

Ecromeximab (Anti-GD3)

Purity & Quality Control

Biological Activity

Description Ecromeximab (Anti-GD3) is a human-mouse chimeric IgG1 monoclonal antibody with potential antineoplastic activity that targets ganglioside GD3, a surface antigen expressed on many malignant melanoma cells. It binds to GD3-positive cells, thereby initiating antibody-dependent cytotoxicity against GD3-positive cells. MW: 145.5 KD.

Product Details

Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ecromeximab (Anti-GD3) | Ecromeximab (Anti-GD3) supplier | purchase Ecromeximab (Anti-GD3) | Ecromeximab (Anti-GD3) cost | Ecromeximab (Anti-GD3) manufacturer | order Ecromeximab (Anti-GD3) | Ecromeximab (Anti-GD3) distributor